Monday 29 September, 2008

Conference

Source: Orange Book Blog and Google

Title: CBI "Paragraph IV Disputes" Conference
Venue: Philadelphia
Date: October 15-16
Agenda:
"Strategies to Optimize Patent Lifecycle from Drafting to Maturity"
"Preparing for Paragraph IV Challenges -- Generic Pre-suit Strategies"
"Best Practices in E-Discovery -- Overcoming Obstacles, Controlling Costs and Maximizing Benefits"
"The KSR Decision and ANDA Litigation"
"Implications of Recent Developments and Trends in Litigating Paragraph IV Disputes" (I'll be speaking on this topic as one of the panelists)
"Citizen Petitions and Their Impact on Generic Entry"
"Interpreting Forfeiture Provisions -- An Analysis of Recent Cases to Increase Preparedness and Improve Product Strategy"
"The FTC, Antitrust Law and Settling Paragraph IV Litigation," presented by Markus Meier, Assistant Director, FTC



Title:
ACI "Maximizing Pharmaceutical Patent Life Cycles" Conference, New York, October 15-16
Venue: New York
Date: October 15-16
Agenda:
"Constructing, Adjusting, and Executing a Pharmaceutical Patent Life Cycle Management Plan"
"View from the FTC," presented by Saralisa Brau, Health Care Services and Products Division, FTC
"Navigating the Complexity of Structuring Patent Settlement Options Between Brand Name and Generic Pharmaceutical Companies"
"Eye on the Bench: Identifying Judicial Trends in Pharmaceutical Patent Cases"
"Mastering the Intricacies of the 180-Day Generic Market Exclusivity"
"Plotting a Course Into Safe Harbor for Branded Pharma"
"View from the FDA," presented by Elizabeth Dickinson, Office of Chief Counsel, FDA
"Slicing Through the Complex Spectrum of Declaratory Judgment Actions in Pharmaceutical Patent Cases"
"Factoring the Role, Challenges, and Impact of Orange Book Listings and Delistings in Patent Portfolio Management"


Title: 2008 Competitive Intelligence Summit
Venue: Rome, Italy
Date: October 20-22
Agenda:
CI and its Relationships with Different Functions Inside the Company
CI Performed by a Single CI Practitioner
CTI: Innovation and Intelligence
Many Facets of Global CI
New Analytical Tools and E-Platforms for the CI Practitioner

No comments:

Blog Archive